Rituximab monotherapy for patients with recurrent primary CNS lymphoma.

作者信息

Batchelor T T, Grossman S A, Mikkelsen T, Ye X, Desideri S, Lesser G J

机构信息

Stephen E. and Catherine Pappas Center for Neuro-Oncology, Yawkey 9E, Massachusetts General Hospital Cancer Center, 55 Fruit Street, Boston, MA 02114, USA.

出版信息

Neurology. 2011 Mar 8;76(10):929-30. doi: 10.1212/WNL.0b013e31820f2d94.

DOI:10.1212/WNL.0b013e31820f2d94

PMID:21383331

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3059144/

Abstract

摘要

相似文献

[1]

Rituximab monotherapy for patients with recurrent primary CNS lymphoma.

Neurology. 2011-3-8

[2]

Primary central nervous system lymphoma treated with rituximab plus temozolomide in a second line schedule.

Clin Transl Oncol. 2007-7

[3]

Combination therapy with rituximab and temozolomide for recurrent and refractory primary central nervous system lymphoma.

Yonsei Med J. 2011-11

[4]

Is there still a need for specific central nervous system directed prophylaxis for diffuse large B-cell lymphoma in the rituximab era?

Leuk Lymphoma. 2014-3

[5]

Immuno-chemotherapy with a combination of rituximab, methotrexate, pirarubicin and procarbazine for patients with primary CNS lymphoma--a preliminary report.

Leuk Lymphoma. 2007-5

[6]

High-dose methotrexate with or without rituximab in newly diagnosed primary CNS lymphoma.

Neurology. 2015-2-17

[7]

Impact of rituximab on incidence of and risk factors for central nervous system relapse in patients with diffuse large B-cell lymphoma: a systematic review and meta-analysis.

Leuk Lymphoma. 2013-7-29

[8]

Rituximab, methotrexate, procarbazine, vincristine and intensified cytarabine consolidation for primary central nervous system lymphoma (PCNSL) in the elderly: a LOC network study.

J Neurooncol. 2017-6

[9]

Central nervous system (CNS) relapse in diffuse large B cell lymphoma (DLBCL): pre- and post-rituximab.

Ann Hematol. 2011-1-13

[10]

Successful treatment of AIDS-associated, primary CNS lymphoma with rituximab- and methotrexate-based chemotherapy and autologous stem cell transplantation.

Infection. 2014-4

引用本文的文献

[1]

Prospective phase II trial of first-line rituximab, methotrexate, and orelabrutinib (R-MO) in primary central nervous system lymphoma.

Blood Cancer J. 2025-4-29

[2]

Optimization and Validation of the Cationization Method for the Fab' Fragment of Antibody Rituximab.

ACS Omega. 2025-3-26

[3]

A phase Ib study evaluating the c-MET inhibitor INC280 (capmatinib) in combination with bevacizumab in patients with high-grade glioma.

Neurooncol Adv. 2024-12-11

[4]

Molecular Mechanisms and Therapeutic Prospects of Immunotherapy and Targeted Therapy in Primary Central Nervous System Lymphoma.

Technol Cancer Res Treat. 2025

[5]

Rituximab in the Treatment of Non-Infectious Uveitis: A Review.

J Inflamm Res. 2024-9-29

[6]

A Phase II Study Assessing Long-term Response to Ibrutinib Monotherapy in Recurrent or Refractory CNS Lymphoma.

Clin Cancer Res. 2024-9-13

[7]

HLA dependency and possible clinical relevance of intrathecally synthesized anti-IgLON5 IgG4 in anti-IgLON5 disease.

Front Immunol. 2024

[8]

Clinical implications of CSF-ctDNA positivity in newly diagnosed diffuse large B cell lymphoma.

Leukemia. 2024-7

[9]

Glofitamab stimulates immune cell infiltration of CNS tumors and induces clinical responses in secondary CNS lymphoma.

Blood. 2024-7-25

[10]

Clinical characteristics and outcomes of Epstein-Barr virus viral load after allogeneic hematopoietic stem cell transplantation.

Ann Hematol. 2024-3

本文引用的文献

[1]

First report on a prospective trial with yttrium-90-labeled ibritumomab tiuxetan (Zevalin) in primary CNS lymphoma.

Neuro Oncol. 2009-8

[2]

Combined immunochemotherapy with reduced whole-brain radiotherapy for newly diagnosed primary CNS lymphoma.

J Clin Oncol. 2007-10-20

[3]

Imaging of central nervous system lymphomas with iodine-123 labeled rituximab.

Eur J Haematol. 2005-4

[4]

Salvage therapy for primary CNS lymphoma with a combination of rituximab and temozolomide.

Neurology. 2004-9-14

[5]

Response criteria for phase II studies of supratentorial malignant glioma.

J Clin Oncol. 1990-7

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

新学期，新优惠

Rituximab monotherapy for patients with recurrent primary CNS lymphoma.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

推荐工具

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献